newsfilter
← Latest News
GlobeNewswire·

CRISPR Therapeutics Provides Business Update and Reports First Quarter 2026 Financial Results

ZUG, Switzerland and BOSTON, May 04, 2026 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ:CRSP) today reported financial results for the first quarter ended March 31, 2026. "The first quarter reflected continued